Asia Pacific Travel Vaccines Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

No. of Pages: 124
Report Code: BMIRE00025509
Category: Life Sciences
Asia Pacific Travel Vaccines Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Travel Vaccines Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Travel Vaccines Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Travel Vaccines Market Regional Analysis

6.2 Asia Pacific Travel Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Travel Vaccines Market Forecast Analysis

7. Asia Pacific Travel Vaccines Market Analysis – by Product

7.1 Hepatitis A
  • 7.1.1 Overview
  • 7.1.2 Hepatitis A: Asia Pacific Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Hepatitis B
  • 7.2.1 Overview
  • 7.2.2 Hepatitis B: Asia Pacific Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Meningococcal Vaccines
  • 7.3.1 Overview
  • 7.3.2 Meningococcal Vaccines: Asia Pacific Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Asia Pacific Travel Vaccines Market Analysis – by Application

8.1 Domestic Travel and Outbound Travel
  • 8.1.1 Overview
  • 8.1.2 Domestic Travel and Outbound Travel : Asia Pacific Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Asia Pacific Travel Vaccines Market – Asia-Pacific Analysis

9.1 Overview

9.2 Asia-Pacific
  • 9.2.1 Asia Pacific Travel Vaccines Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.2.1.1 Asia Pacific Travel Vaccines Market – Revenue and Forecast Analysis – by Country
  • 9.2.1.1 China: Asia Pacific Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.1.1 China: Asia Pacific Travel Vaccines Market Breakdown, by Product
    • 9.2.1.1.2 China: Asia Pacific Travel Vaccines Market Breakdown, by Application
  • 9.2.1.2 India: Asia Pacific Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.2.1 India: Asia Pacific Travel Vaccines Market Breakdown, by Product
    • 9.2.1.2.2 India: Asia Pacific Travel Vaccines Market Breakdown, by Application
  • 9.2.1.3 Japan: Asia Pacific Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.3.1 Japan: Asia Pacific Travel Vaccines Market Breakdown, by Product
    • 9.2.1.3.2 Japan: Asia Pacific Travel Vaccines Market Breakdown, by Application
  • 9.2.1.4 Australia: Asia Pacific Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.4.1 Australia: Asia Pacific Travel Vaccines Market Breakdown, by Product
    • 9.2.1.4.2 Australia: Asia Pacific Travel Vaccines Market Breakdown, by Application
  • 9.2.1.5 Rest of Asia-Pacific : Asia Pacific Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Travel Vaccines Market Breakdown, by Product
    • 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Travel Vaccines Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments

12. Company Profiles

12.1 Abbott
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Bharat Biotech
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Emergent BioSolutions Inc.
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 GlaxoSmithKline plc
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Merck & Co., Inc.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Novartis AG
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Pfizer Inc.
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Sanofi
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights
13.2 List of Abbreviations

The List of Companies - Asia Pacific Travel Vaccines Market

  • Abbott
  • Bharat Biotech
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)